BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:51 PM
 | 
Jul 01, 2010
 |  BC Extra  |  Company News

FDA approves Purdue's Butrans

FDA approved an NDA from Purdue Pharma L.P. (Stamford, Conn.) for Butrans buprenorphine transdermal system for the...

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >